{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:15:25Z","timestamp":1778645725905,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:00:00Z","timestamp":1639180800000},"content-version":"am","delay-in-days":254,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jiac.2020.11.023","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T18:51:11Z","timestamp":1607712671000},"page":"617-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infection"],"prefix":"10.1016","volume":"27","author":[{"given":"Shunsuke","family":"Akashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maho","family":"Suzukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2935-5553","authenticated-orcid":false,"given":"Keita","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Asari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuharu","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9982-3717","authenticated-orcid":false,"given":"Akira","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8648-2191","authenticated-orcid":false,"given":"Atsuhisa","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Tohma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuji","family":"Teruya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jiac.2020.11.023_bib1","first-page":"1226","article-title":"The diagnosis and misdiagnosis of tuberculosis","volume":"12","author":"Davies","year":"2008","journal-title":"Int J Tubercul Lung Dis"},{"issue":"10024","key":"10.1016\/j.jiac.2020.11.023_bib2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(15)00151-8","article-title":"Tuberculosis","volume":"387","author":"Dheda","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2020.11.023_bib3","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.jiac.2020.11.023_bib4","first-page":"588","article-title":"First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB plus","volume":"73","author":"Petruccioli","year":"2016","journal-title":"J\u00a0Infect"},{"issue":"3","key":"10.1016\/j.jiac.2020.11.023_bib5","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3201\/eid2403.171633","article-title":"Characteristics associated with negative interferon-gamma release assay results in culture-confirmed tuberculosis patients, Texas, USA, 2013-2015","volume":"24","author":"Nguyen","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.jiac.2020.11.023_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12879-018-3344-x","article-title":"Predictors for false-negative QuantiFERON-TB Gold assay results in patients with extrapulmonary tuberculosis","volume":"18","author":"Kim","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.jiac.2020.11.023_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152483","article-title":"Combined analysis of IFN-gamma, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT supernatant is useful for distinguishing active tuberculosis from latent infection","volume":"11","author":"Suzukawa","year":"2016","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.jiac.2020.11.023_bib8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1164\/rccm.201501-0059OC","article-title":"Mycobacteria-specific cytokine responses detect tuberculosis infection and distinguish latent from active tuberculosis","volume":"192","author":"Tebruegge","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jiac.2020.11.023_bib9","first-page":"281","article-title":"Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease","volume":"74","author":"Won","year":"2017","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jiac.2020.11.023_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2466-9-21","article-title":"Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report","volume":"9","author":"Chegou","year":"2009","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.jiac.2020.11.023_bib11","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1086\/315771","article-title":"Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis","volume":"182","author":"Juffermans","year":"2000","journal-title":"J\u00a0Infect Dis"},{"issue":"12","key":"10.1016\/j.jiac.2020.11.023_bib12","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41564-019-0578-3","article-title":"Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1Ra","volume":"4","author":"Ji","year":"2019","journal-title":"Nat Microbiol"},{"issue":"3","key":"10.1016\/j.jiac.2020.11.023_bib13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1034\/j.1399-3003.1999.14c03.x","article-title":"Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary TB","volume":"14","author":"Tsao","year":"1999","journal-title":"Eur Respir J"},{"issue":"4 Pt 1","key":"10.1016\/j.jiac.2020.11.023_bib14","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1164\/ajrccm.157.4.9709126","article-title":"Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis","volume":"157","author":"Juffermans","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jiac.2020.11.023_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1378\/chest.117.1.103","article-title":"Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis","volume":"117","author":"Tsao","year":"2000","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.jiac.2020.11.023_bib16","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.189.12.1863","article-title":"Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis","volume":"189","author":"Wilkinson","year":"1999","journal-title":"J\u00a0Exp Med"},{"issue":"12","key":"10.1016\/j.jiac.2020.11.023_bib17","article-title":"Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population","volume":"7","author":"Wang","year":"2012","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.jiac.2020.11.023_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1128\/JCM.01646-16","article-title":"Highly multiplexed proteomic analysis of quantiferon supernatants to identify biomarkers of latent tuberculosis infection","volume":"55","author":"De Groote","year":"2017","journal-title":"J\u00a0Clin Microbiol"},{"issue":"4","key":"10.1016\/j.jiac.2020.11.023_bib19","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1164\/ajrccm.155.4.9105097","article-title":"Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients","volume":"155","author":"Kurashima","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jiac.2020.11.023_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1165\/ajrcmb.19.3.2815","article-title":"Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis","volume":"19","author":"Sadek","year":"1998","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"11","key":"10.1016\/j.jiac.2020.11.023_bib21","doi-asserted-by":"crossref","first-page":"7474","DOI":"10.4049\/jimmunol.175.11.7474","article-title":"Coordinate expression of CC chemokine ligand 5, granulysin, and perforin in CD8+ T cells provides a host defense mechanism against Mycobacterium tuberculosis","volume":"175","author":"Stegelmann","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.jiac.2020.11.023_bib22","first-page":"480","article-title":"Polymorphisms in CCL5 promoter are associated with pulmonary tuberculosis in northern Spain","volume":"13","author":"Sanchez-Castanon","year":"2009","journal-title":"Int J Tubercul Lung Dis"},{"issue":"8","key":"10.1016\/j.jiac.2020.11.023_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072139","article-title":"A\u00a0meta-analysis of the association between the CC chemokine ligand 5 (CCL5) -403 G>A gene polymorphism and tuberculosis susceptibility","volume":"8","author":"Areeshi","year":"2013","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.jiac.2020.11.023_bib24","first-page":"281","article-title":"Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection","volume":"78","author":"Luo","year":"2019","journal-title":"J\u00a0Infect"},{"issue":"5","key":"10.1016\/j.jiac.2020.11.023_bib25","first-page":"456","article-title":"Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV\/TB co-infected patients","volume":"74","author":"Nouhin","year":"2017","journal-title":"J\u00a0Infect"},{"issue":"5","key":"10.1016\/j.jiac.2020.11.023_bib26","first-page":"547","article-title":"Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis","volume":"80","author":"Suzukawa","year":"2020","journal-title":"J\u00a0Infect"},{"issue":"11","key":"10.1016\/j.jiac.2020.11.023_bib27","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jiac.2020.06.019","article-title":"Comparison of QuantiFERON-TB Gold plus, QuantiFERON-TB Gold in-tube, and T-SPOT.TB among patients with tuberculosis","volume":"26","author":"Takeda","year":"2020","journal-title":"J\u00a0Infect Chemother"},{"issue":"7","key":"10.1016\/j.jiac.2020.11.023_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00614-18","article-title":"Comparison of the QuantiFERON-TB Gold plus and QuantiFERON-TB Gold in-tube interferon gamma release assays in patients at risk for tuberculosis and in health care workers","volume":"56","author":"Theel","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.jiac.2020.11.023_bib29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jiac.2017.10.009","article-title":"Sensitivity and specificity of QuantiFERON-TB Gold plus compared with QuantiFERON-TB Gold in-tube and T-SPOT.TB on active tuberculosis in Japan","volume":"24","author":"Takasaki","year":"2018","journal-title":"J\u00a0Infect Chemother"},{"issue":"5","key":"10.1016\/j.jiac.2020.11.023_bib30","first-page":"444","article-title":"QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis","volume":"79","author":"Sotgiu","year":"2019","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jiac.2020.11.023_bib31","doi-asserted-by":"crossref","first-page":"30617","DOI":"10.1038\/srep30617","article-title":"Evaluation of QuantiFERON-TB Gold plus for detection of Mycobacterium tuberculosis infection in Japan","volume":"6","author":"Yi","year":"2016","journal-title":"Sci Rep"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2030430X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2030430X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:01:43Z","timestamp":1761159703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X2030430X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1341321X2030430X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2020.11.023","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2020.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}